Varian chosen for Netherlands radiology project

The Tilburg, Netherlands-based Dr. Bernard Verbeeten Institute (BVI) ordered five medical linear accelerators from Varian Medical Systems, which will deliver radiotherapy treatments. The new machines, which include one Trilogy linear accelerator, will be stationed at the institute's headquarters and at two new satellite centers being constructed in the nearby cities of Breda and Den Bosch, according to the Palto, Calif.-based company.

"Both these cities have large populations but they have never had any radiotherapy facility in the city-based hospitals and patients have had to travel more than thirty kilometres to Tilburg,” said Jack Venselaar, medical physicist at the oncology clinic.

According to Varian, in early 2008 construction will begin on the new radiotherapy treatment rooms alongside the new hospital site in Den Bosch and the existing hospital in Breda. Both new radiotherapy departments will remain part of the BVI and be independent of the adjacent hospitals. All machines should be installed and operating clinically by the summer of 2009.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.